Epix tests drug for depression/anxiety
United Press International - depression data obtained last year from our clinical trial of PRX-00023 in patients with a primary diagnosis of generalized anxiety disorder," said Michael Kauffman, Epix's CEO. He said there is an unmet medical need for a depression treatment as
Source: www.upi.com
Preliminary Program: Thursday, May 24
Psychiatric News - Depression Treatment From a Primary Care Physician Perspective Paul E. Hubley, M.D. A Psychiatry Perspective on Mental Health/Primary Care Integration Claudio O. Cabrejos, M.D. S78. The Psychopathology of Personality: Perspectives From the Collaborative
Source: pn.psychiatryonline.org
Click here for more information about information on depression 2 information on depression 2
<< Home